The regulatory environment workstream is trying to maximise innovative processes by highlighting existing regulatory flexibility and the positive UK regulatory landscape to industry.
One of the ways it is doing this is by partnering with the Medicines and Healthcare Products Regulatory Agency (MHRA) to produce case studies on regulatory collaboration between medicines manufacturers and the MHRA Innovation Office. Further details on the MHRA Innovation Office and the case studies can be found here.
Last modified: 20 September 2023
Last reviewed: 20 September 2023